IRIS
IANNONE, ROSA FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 916
EU - Europa 460
AS - Asia 451
SA - Sud America 78
AF - Africa 17
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 899
SG - Singapore 182
RU - Federazione Russa 120
CN - Cina 100
IE - Irlanda 89
HK - Hong Kong 61
BR - Brasile 57
DE - Germania 55
SE - Svezia 55
VN - Vietnam 47
FR - Francia 31
UA - Ucraina 26
IT - Italia 18
FI - Finlandia 17
GB - Regno Unito 13
BD - Bangladesh 12
CZ - Repubblica Ceca 10
IN - India 10
CA - Canada 9
EC - Ecuador 8
AT - Austria 7
MX - Messico 6
NL - Olanda 6
DZ - Algeria 5
IQ - Iraq 5
PK - Pakistan 5
UZ - Uzbekistan 5
PL - Polonia 4
VE - Venezuela 4
AR - Argentina 3
IR - Iran 3
JP - Giappone 3
LT - Lituania 3
TR - Turchia 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CO - Colombia 2
EG - Egitto 2
KG - Kirghizistan 2
MA - Marocco 2
NP - Nepal 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
ES - Italia 1
GY - Guiana 1
HN - Honduras 1
ID - Indonesia 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
PW - Palau 1
RO - Romania 1
SC - Seychelles 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 1.925
Salva come PNG Salva come JPEG
Città #
Dallas 418
San Jose 170
Dublin 88
Singapore 83
Hong Kong 61
Ashburn 53
Beijing 36
Chandler 34
Nyköping 34
Munich 32
Santa Clara 22
Lauterbourg 20
Ho Chi Minh City 18
Los Angeles 18
The Dalles 14
Hanoi 13
Helsinki 13
Jacksonville 13
Columbus 12
Moscow 12
Brno 10
Nuremberg 10
Chicago 7
Princeton 7
Wilmington 7
London 6
New York 6
Amsterdam 5
Brooklyn 5
Falkenstein 5
Frankfurt am Main 4
Guangzhou 4
Loja 4
Shanghai 4
Tashkent 4
Toronto 4
Turku 4
Xi'an 4
Algiers 3
Boston 3
Chennai 3
Guayaquil 3
Hải Dương 3
Mexico City 3
Paris 3
Rio de Janeiro 3
São Paulo 3
Vienna 3
Warsaw 3
Atlanta 2
Baghdad 2
Baku 2
Caracas 2
Dakar 2
Dhaka 2
Foggia 2
Guiyang 2
Haiphong 2
Hangzhou 2
Hillsboro 2
Islamabad 2
Lahore 2
Milan 2
Montevideo 2
New Delhi 2
Phoenix 2
Rome 2
Seattle 2
Tokyo 2
Washington 2
Welland 2
Abuja 1
Aci Catena 1
Ahmedabad 1
Amman 1
Amparo 1
Andradina 1
Ankara 1
Antalya 1
Araçatuba 1
Arraial do Cabo 1
Aryanah 1
Ash Shuhada' 1
Astrakhan 1
Azcapotzalco 1
Baguio City 1
Balsas 1
Bari 1
Batam 1
Belo Horizonte 1
Benoni 1
Bethany 1
Bishkek 1
Blumenau 1
Boardman 1
Bom Jesus 1
Brasília 1
Bucaramanga 1
Buffalo 1
Buon Ma Thuot 1
Totale 1.370
Salva come PNG Salva come JPEG
Nome #
Transthoracic Lung Ultrasound in Systemic Sclerosis-Associated Interstitial Lung Disease: Capacity to Differentiate Chest Computed-Tomographic Characteristic Patterns 190
Nintedanib in Rheumatoid Arthritis–Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 139
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry 128
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients 122
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 113
Preliminary data on post market safety profiles of covid 19 vaccines in rheumatic diseases: Assessments on various vaccines in use, different rheumatic disease subtypes, and immunosuppressive therapies: A two-centers study 113
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 112
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 100
Factors predicting early discontinuation of methotrexate as a first-line treatment for rheumatoid arthritis in Italy: Results from the GISEA registry 89
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA 89
Racial differences in systemic sclerosis disease presentation: A European Scleroderma Trials and Research group study 85
Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: A retrospective analysis 81
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium 71
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 67
Retention rate of a second line with a biologic DMARD after failure of a first-line therapy with abatacept, tocilizumab, or rituximab: results from the Italian GISEA registry 61
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs 59
Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database 59
Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: A EUSTAR database analysis 59
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research 56
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis 55
Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission 53
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry 52
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study 48
Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081)) 22
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database 4
Totale 2.027
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202260 0 1 0 0 7 1 0 6 11 24 0 10
2022/2023205 14 11 12 5 9 20 0 22 92 5 13 2
2023/202479 4 3 6 6 8 12 0 1 0 6 7 26
2024/2025352 15 5 4 13 7 53 42 28 78 31 38 38
2025/20261.269 69 147 436 71 37 44 171 104 51 78 38 23
Totale 2.027